Detalles de la búsqueda
1.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496541
2.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
3.
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
Br J Haematol
; 179(3): 410-420, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990173
4.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662018
5.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549589
6.
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Br J Haematol
; 168(6): 824-34, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25546611
7.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31413097
8.
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
Br J Haematol
; 161(2): 237-44, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432431
9.
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial.
Hemasphere
; 7(7): e917, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427145
10.
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Hemasphere
; 7(7): e904, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427146
11.
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
Oncol Res Treat
; 45(6): 319-325, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915492
12.
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
Blood Adv
; 6(5): 1394-1405, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34794176
13.
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
Hemasphere
; 5(7): e600, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179697
14.
Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia.
Cancers (Basel)
; 13(9)2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33926021
15.
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
Blood Adv
; 5(17): 3279-3289, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459887
16.
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Leukemia
; 35(9): 2517-2525, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603142
17.
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.
J Cancer Res Clin Oncol
; 146(4): 1065-1077, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076823
18.
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis.
Leukemia
; 33(11): 2710-2719, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31462732
19.
Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
Am J Med Sci
; 335(5): 394-7, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18480659
20.
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
J Thorac Oncol
; 11(1): 85-93, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26762743